OakChart

United Therapeutics Corp

UTHRHealthcare·Drug Manufacturers - Specialty & Generic·USA·Large·NASD·Nov 11 • 2:53 PM ET

597.97+9.36 (1.59%)
2026-11-11 20:53 CET
Market cap
25,068.13 USD m
Revenue, TTM
3,187.50 USD m
Net income, TTM
1,230.80 USD m
Free cash flow, TTM
863.80 USD m
EPS diluted, TTM
26.51
P/E
22.56
Compare

Price

UTHR against its 20, 50 and 200-day averages
2050200beatmiss
500.00550.00600.001.7M3.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26UTHRclose 597.9720-day 578.6550-day 538.60200-day 536.22597.9752w high

2.6% under the 52-week high of 614.23 on 4 Nov 2026. 52-week low 449.58 on 11 Nov 2025. Last 15 sessions, 10.3% high to low

Profile

UTHR
52-week range, 90% of the way up
449.58614.23

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

IndexRUI
Employees1400
IPOJun 17, 1999
Beta0.49
ATR, 14d19.20
Rel volume0.29
Short float4.46%
Insider own3.31%
Inst own98.76%

Snapshot

6 groups

Valuation

IndexRUI
Market Cap25.47B
Enterprise Value23.40B
Income1.23B
Sales3.19B
Book/sh148.08
Cash/sh48.56
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees1400
IPOJun 17, 1999

Ratios

P/E22.56
Forward P/E20.08
PEG2.76
P/S7.99
P/B4.04
P/C12.32
P/FCF29.48
EV/EBITDA15.76
EV/Sales7.34
Quick Ratio4.29
Current Ratio4.61
Debt/Eq0.00
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)26.51
EPS next Y29.78
EPS next Q4.95
EPS this Y-11.52%
EPS next Y20.80%
EPS next 5Y7.28%
EPS past 3/5Y22.94% 19.27%
Sales past 3/5Y18.02% 16.50%
EPS Y/Y TTM0.33%
Sales Y/Y TTM1.89%
EPS Q/Q-20.28%
Sales Q/Q4.13%
EarningsNov 04 BMO
EPS/Sales Surpr.-4.94% 6.57%

Ownership

Insider Own3.31%
Insider Trans-50.79%
Inst Own98.76%
Inst Trans-1.31%
ROA17.11%
ROE19.13%
ROIC19.61%
Gross Margin86.34%
Oper. Margin43.56%
Profit Margin38.61%
SMA203.34%
SMA5011.02%
SMA20011.52%
Trades-

Technical

Shs Outstand42.38M
Shs Float41.18M
Short Float4.46%
Short Ratio2.63
Short Interest1.84M
52W High614.23 -2.65%
52W Low449.58 33.01%
Volatility4.90% 3.27%
ATR (14)19.20
RSI (14)60.76
Beta0.49
Rel Volume0.29
Avg Volume698.43K
Volume167,923

Performance

Perf Week-1.73%
Perf Month10.04%
Perf Quarter19.29%
Perf Half Y3.18%
Perf YTD22.72%
Perf Year30.22%
Perf 3Y168.34%
Perf 5Y197.65%
Perf 10Y370.84%
Recom1.53
Target Price687.14
Prev Close588.61
Price597.97
Change %1.59%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Nov 09, 2026ResumedHH.C. WainwrightBuy$660+10.4%
Nov 09, 2026InitiatedHH.C. WainwrightBuy$660+10.4%
Oct 01, 2026UpgradeBBTIG ResearchNeutral → Buy$728+21.7%
Sep 24, 2026InitiatedGGoldmanSell$321-46.3%
May 07, 2026UpgradeWWells FargoEqual Weight → Overweight$735+22.9%
Apr 10, 2026InitiatedRRaymond JamesOutperform$700+17.1%
Oct 20, 2025InitiatedWWells FargoUnderweight$414-30.8%
Sep 26, 2025InitiatedRRBC Capital MktsOutperform$569-4.8%
Jun 02, 2025InitiatedCCantor FitzgeraldOverweight$405-32.3%
Apr 25, 2025DowngradeWWells FargoOverweight → Equal Weight

Peers

Mkt cap
TickerCompanyMkt cap
LQDALiquidia Corp4.90B
INSMInsmed Inc26.26B
MRKMerck & Co Inc360.44B
NBIXNeurocrine Biosciences Inc17.53B
ALKSAlkermes plc7.97B
JNJJohnson & Johnson673.83B
MNKDMannkind Corp1.35B
JAZZJazz Pharmaceuticals plc15.85B
GOSSGossamer Bio Inc69.48M
BMRNBiomarin Pharmaceutical Inc11.26B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
ROTHBLATT MARTINE AChairperson & CEONov 09 '26Sale584.591,614943,521324,443Nov 10 04:35 PM
ROTHBLATT MARTINE AChairperson & CEONov 09 '26Option Exercise117.769,5001,118,720333,943Nov 10 04:35 PM
ROTHBLATT MARTINE AChairperson & CEONov 09 '26Sale572.697,8864,516,253326,057Nov 10 04:35 PM
PATUSKY CHRISTOPHERDirectorNov 09 '26Option Exercise132.301,210160,0833,350Nov 10 04:34 PM
PATUSKY CHRISTOPHERDirectorNov 09 '26Sale580.001,210701,8002,140Nov 10 04:34 PM
ROTHBLATT MARTINE AChairperson & CEONov 06 '26Option Exercise117.769,5001,118,720333,943Nov 09 05:41 PM
ROTHBLATT MARTINE AChairperson & CEONov 06 '26Sale564.519,5005,362,824324,443Nov 09 05:41 PM
CHRISTOPHER PATUSKYDirectorNov 09 '26Proposed Sale580.001,210701,800Nov 09 05:00 PM
ROTHBLATT MARTINE AChairperson & CEONov 05 '26Sale597.761,9601,171,609324,443Nov 06 04:57 PM
ROTHBLATT MARTINE AChairperson & CEONov 05 '26Option Exercise117.769,5001,118,720333,943Nov 06 04:54 PM
ROTHBLATT MARTINE AChairperson & CEONov 05 '26Sale573.897,5404,327,122326,403Nov 06 04:54 PM
ROTHBLATT MARTINE AChairperson & CEONov 04 '26Sale611.061,7231,052,854324,443Nov 05 05:21 PM
ROTHBLATT MARTINE AChairperson & CEONov 04 '26Option Exercise117.769,5001,118,720333,943Nov 05 05:21 PM
ROTHBLATT MARTINE AChairperson & CEONov 04 '26Sale599.647,7774,663,396326,166Nov 05 05:21 PM

Held by

AUM
TickerCompanyAUM
IJHiShares Core S&P Mid-Cap ETFAUM: 124.48B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
VXFVanguard Extended Market Index ETFAUM: 30.47B
MDYState Street SPDR S&P MIDCAP 400 ETF TrustAUM: 26.22B
IBBiShares Biotechnology ETFAUM: 11.36B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
XMHQInvesco S&P MidCap Quality ETFAUM: 5.81B
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
XMMOInvesco S&P MidCap Momentum ETFAUM: 6.37B

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-045.7106.0075.710832.5781.1414
2026Q22026-08-057.2706.8627.271783.3804.6512
2026Q12026-05-065.8206.9985.824781.5797.411
2025Q42026-02-257.7007.1307.702790.2813.0812
2025Q32025-10-297.1607.3177.161799.5812.8413
2025Q22025-07-306.4107.2956.408798.6801.879
2025Q12025-04-306.6306.6966.630794.4729.3311
2024Q42025-02-266.1906.4006.187735.9734.7310
2024Q32024-10-306.3906.5236.386748.9722.6212
2024Q22024-07-315.8506.4855.855714.9691.8712
2024Q12024-05-016.1705.7066.169677.7620.3112
2023Q42024-02-214.3604.2854.359614.7575.0110
2023Q32023-11-015.3805.1025.384609.4585.8211
2023Q22023-08-025.2404.5695.236596.5524.188
2023Q12023-05-034.8604.5884.857506.9514.3710
2022Q42023-02-222.6704.7222.674491.5519.219

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-2.390-0.820-2.3861,4491,495
2020FY11.54012.76811.5431,4831,460
2021FY15.26011.38110.0591,6861,698
2022FY15.00017.51614.9961,9361,963
2023FY19.81019.74919.8152,3282,289
2024FY24.64024.40724.6412,8772,874
2025FY27.86027.47927.8643,1833,200
2026FY-24.650--3,251
2027FY-29.778--3,621
2028FY-34.402--4,108
2029FY-43.118--4,950
2030FY-51.240--5,911

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-0613103861.62693.181,156
2026Q4S2026-11-041393856.07693.181,156
2026Q4S2026-11-011362833.637321,080
2026Q4S2026-10-271363833.637321,080
2026Q4S2026-10-231372842.47321,080
2026Q4S2026-10-211363840.47321,080
2026Q4S2026-10-201372847.947321,080
2026Q4S2026-10-191373847.947321,080
2026Q4S2026-10-161366847.027321,080
2026Q4S2026-10-141356833.937321,080
2026Q4S2026-10-121346827.247321,080
2026Q4S2026-10-091337807.62732950
2026Q4S2026-10-071237812.72732950
2026Q4S2026-10-051228802.81732913

Estimate history

EPS, annual9.3113.391-2.38611.54310.05914.99619.81524.64127.86426.5054
Period201720182019202020212022202320242025TTM
EPS, quarterly6.3866.1876.636.4087.1617.7025.8247.2715.709
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual1725.31627.81448.81483.31685.51936.32327.52877.43182.73187.5
Period201720182019202020212022202320242025TTM
Sales, quarterly748.9735.9794.4798.6799.5790.2781.5783.3832.5
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual43.2443.58843.88544.50745.10846.03247.04144.83143.64342.382
Period201720182019202020212022202320242025MRQ
Shares, quarterly44.61644.83145.07545.21542.90343.64342.15642.67742.382
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue3,187.503,182.702,877.402,327.501,936.301,685.501,483.301,448.801,627.80
Cost of Goods Sold Incl. D&A435.40384.40309.70257.50151.60122.50108.10117.60198.70
Gross Profit2,752.102,798.302,567.702,070.001,784.701,563.001,375.201,331.201,429.10
Selling, General and Administrative Excl. Other1,363.701,281.101,190.70881.50793.80874.50776.20710.00618.30
Research and Development703.20550.00481.00408.00322.90410.00352.30373.80357.90
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income1,388.401,517.201,377.001,188.50990.90688.50599.00621.20810.80
Interest Expense11.9019.5042.9059.3032.4018.6023.5044.2013.90
Unusual Expense-73.40-18.300.003.6012.90134.90-9.10787.4058.90
Net Income Before Taxes1,507.801,713.901,539.001,274.30950.60593.90638.90-165.00758.90
Income Taxes277.00379.20343.90289.50223.30118.10124.10-60.50169.70
Consolidated Net Income1,230.801,334.701,195.10984.80727.30475.80514.80-104.50589.20
Net Income From Continuing Operations1,230.801,334.701,195.10984.80727.30475.80514.80-104.50589.20
Net Income1,230.801,334.701,195.10984.80727.30475.80514.80-104.50589.20
EPS (Recurring)26.0427.6024.6419.8715.1812.0611.4010.2014.33
EPS (Basic, Before Extraordinaries)28.6130.1326.4421.0415.9810.6011.65-2.3913.54
EPS (Diluted)26.5127.8624.6419.8115.0010.0611.54-2.3913.39
EBITDA1,484.401,602.801,449.501,241.701,042.20738.40648.90667.10846.70
Non-Operating Income (Expense)57.90197.90204.90148.705.0058.9054.3045.4020.90
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense87.00130.40113.7630.89106.80101.11119.5735.05-20.35
Price To Earnings Ratio22.2122.2115.5012.1118.9221.5613.13-8.09
Price To Sales Ratio7.707.335.954.706.976.064.562.662.94
Gross Margin86.3487.9289.2488.9492.1792.7392.7191.8887.79
Operating Margin43.5647.6747.8651.0651.1740.8540.3842.8849.81
Net Margin38.6141.9441.5342.3137.5628.2334.71-7.2136.20
Shares Outstanding42.3843.6444.8347.0446.0345.1144.5143.8843.59
Market Capitalization25,068.1325,068.1315,752.3710,333.4212,674.519,731.496,745.623,865.044,746.62

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue832.50783.30781.50790.20799.50798.60794.40735.90
Cost of Goods Sold Incl. D&A99.1099.50133.40103.40100.9087.6092.5075.90
Gross Profit733.40683.80648.10686.80698.60711.00701.90660.00
Selling, General and Administrative Excl. Other359.10353.00322.30329.30309.30324.80319.10302.30
Research and Development279.20146.30138.20139.50127.50134.00149.00133.80
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income374.30330.80325.80357.50389.30386.20382.80357.70
Interest Expense2.902.903.003.103.007.306.107.90
Unusual Expense47.30-13.40-61.60-45.70-5.0025.700.000.00
Net Income Before Taxes372.80372.70318.30444.00438.00408.40423.50396.50
Income Taxes114.2039.7043.4079.7099.3098.90101.3095.20
Consolidated Net Income258.60333.00274.90364.30338.70309.50322.20301.30
Net Income From Continuing Operations258.60333.00274.90364.30338.70309.50322.20301.30
Net Income258.60333.00274.90364.30338.70309.50322.20301.30
EPS (Recurring)6.447.074.917.037.096.786.636.19
EPS (Basic, Before Extraordinaries)6.067.826.328.417.736.867.186.74
EPS (Diluted)5.717.275.827.707.166.416.636.19
EBITDA400.70355.00348.40380.30411.20407.30402.60377.40
Non-Operating Income (Expense)48.7031.40-66.1043.9046.7055.2046.8046.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense32.3912.5011.3030.8130.8929.8628.0021.33
Price To Earnings Ratio22.2120.0021.2518.4716.3711.4712.5315.50
Price To Sales Ratio7.707.878.837.246.344.515.005.97
Gross Margin88.1087.3082.9386.9187.3889.0388.3689.69
Operating Margin44.9642.2341.6945.2448.6948.3648.1948.61
Net Margin31.0642.5135.1846.1042.3638.7640.5640.94
Shares Outstanding42.3842.6842.1643.6442.9045.2245.0744.83
Market Capitalization25,068.1322,998.9025,988.9520,979.3318,959.3212,961.3813,845.0815,752.37

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments2,920.303,267.002,994.102,838.701,930.701,835.001,485.901,415.90927.40
Short Term Receivables350.20279.30278.90220.40198.70157.40151.40175.70297.10
Inventories183.10157.90111.80102.0093.8086.5093.40101.00107.90
Other Current Assets248.90169.70166.20219.2098.0085.90130.4075.40115.50
Total Current Assets3,702.503,873.903,551.003,380.302,321.202,164.801,861.101,768.001,447.90
Net Property, Plant & Equipment1,729.701,222.401,045.40861.50780.90731.60743.30699.70545.70
Total Investments and Advances1,830.501,534.301,938.301,344.701,681.001,234.40853.50447.60563.10
Intangible Assets116.50111.90114.2044.5044.60158.10158.30170.8045.60
Deferred Tax Assets446.80532.80437.20368.70291.90266.00275.50149.00132.50
Other Assets143.10163.10123.3085.8079.5087.5067.20219.20163.70
Total Assets7,969.107,438.407,209.406,085.505,199.104,642.403,958.903,454.302,898.50
Short Term Debt Incl. Current Port. of LT Debt0.00300.00400.000.000.000.00251.800.000.00
Accounts Payable7.106.005.604.103.804.109.9023.108.40
Other Current Liabilities553.50432.10398.80339.10301.60319.20201.30253.50436.30
Total Current Liabilities560.60738.10804.40343.20305.40323.30463.00276.60444.70
Long Term Debt0.000.00300.00800.00800.00800.00603.00250.00250.00
Provision for Risks Charges61.3046.0039.4051.7069.7066.6052.0013.4012.80
Deferred Tax Liabilities89.1074.4042.4041.0030.0027.4045.5053.3019.10
Other Liabilities161.90135.9038.4052.9035.1029.9015.0053.2050.90
Total Liabilities872.90994.401,224.601,288.801,240.201,247.201,178.50646.50777.50
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.0019.2019.20
Common Equity7,096.206,444.005,984.804,796.703,958.903,395.202,780.402,788.602,101.80
Total Shareholders Equity7,096.206,444.005,984.804,796.703,958.903,395.202,780.402,807.802,121.00
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity7,096.206,444.005,984.804,796.703,958.903,395.202,780.402,807.802,121.00
Total Liabilities & Stockholders Equity7,969.107,438.407,209.406,085.505,199.104,642.403,958.903,454.302,898.50
Book Value Per Share162.60143.74127.23104.2087.7776.2863.3663.9848.61
Tangible Book Value Per Share159.93141.24124.80103.2486.7872.7359.7560.0647.55
Full-Time Employees1,4001,3051,168985965950920860800
Price to Book Ratio3.972.581.812.782.461.991.391.703.09
Return on Assets17.3316.3214.8112.899.6711.97-2.8218.5515.90
Return on Equity19.7119.2318.2716.6112.9416.67-3.7423.9120.98
Return on Invested Capital18.8118.5515.6713.0010.0012.27-3.0919.2717.63
Quick Ratio6.285.034.289.557.296.433.826.033.01
Current Ratio6.605.254.419.857.606.704.026.393.26

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income1,230.801,334.701,195.10984.80727.30475.80514.80-104.50589.20
Depreciation96.0085.6072.5053.2051.3049.9049.9045.9035.90
Other Funds (Non Cash)195.00149.70117.0037.80157.60246.70129.6032.9028.90
Funds from Operations1,719.601,667.701,384.601,075.80936.20772.40694.30-25.70654.00
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-293.40-106.50-60.20-97.80-141.20-174.2059.70-180.90124.40
Cash from Operating Activities1,426.201,561.201,324.40978.00795.00598.20754.00-206.60778.40
Capital Expenditures-562.40-526.00-246.50-230.40-138.80-120.80-59.30-83.70-184.40
Net Assets From Acquisitions0.000.000.00-89.200.000.000.000.00-124.10
Sale of Fixed Assets and Businesses0.000.000.000.000.000.002.400.000.00
Purchase or Sale of Investments640.80-14.90692.20-377.00-676.20-366.10-681.60-239.20-466.10
Purchase of Investments-1,900.00-3,460.40-1,676.60-2,514.30-1,710.10-1,895.30-2,308.80-1,279.50-867.00
Sale Or Maturity of Investments2,540.803,445.502,368.802,137.301,033.901,529.201,627.201,040.30400.90
Other Uses-4.80-10.40-28.50-23.000.000.000.00-12.50-46.00
Other Sources19.400.000.000.003.500.000.000.000.00
Cash from Investing Activities93.00-551.30417.20-719.60-811.50-486.90-738.50-335.40-820.60
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-1,608.40-816.90-839.90104.6094.3055.6038.5014.0019.50
Repurchase of Common Pref Stock-2,000.00-1,000.00-1,000.000.000.000.000.000.000.00
Sale of Common Pref Stock391.60183.10160.10104.6094.3055.6038.5014.0019.50
Proceedsfrom Stock Options9.209.207.606.605.905.604.704.103.90
Issuance or Reduction of Debt, Net0.00-311.50-400.00-100.000.000.00-50.00599.30-13.20
Change in Long Term Debt0.00-311.50-400.00-100.000.000.00-50.00599.30-13.20
Issuance of Long Term Debt0.00188.500.000.00800.000.000.00799.30236.80
Reduction of Long Term Debt0.00-500.00-400.00-100.00-800.000.00-50.00-200.00-250.00
Net Financing Active Other Cash Flow-62.00-21.60-12.20-13.80-11.40-10.80-3.70-2.100.00
Other Financing Activities Uses-62.00-21.60-12.20-13.80-11.40-10.80-3.70-2.100.00
Cash from Financing Activities-1,670.40-1,150.00-1,252.10-11.9082.9044.80-15.20611.206.30
Exchange Rate Effect-------0.000.00
Net Change in Cash-151.20-140.10489.50246.5066.40156.100.3069.20-35.90
Free Cash Flow863.801,040.701,077.90747.60656.20477.40694.70-290.30594.00
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow28.4222.4315.8814.6220.5521.419.74-8.07
Deferred Taxes & Investment Tax Credit-97.700.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments2,067.902,662.302,153.702,920.302,767.603,048.70
Short Term Receivables348.60310.30312.00350.20297.70379.30
Inventories201.90193.80178.30183.10176.50169.20
Other Current Assets261.80317.30228.00248.90252.20229.70
Total Current Assets2,880.203,483.702,872.003,702.503,494.003,826.90
Net Property, Plant & Equipment2,041.901,930.101,840.701,729.701,555.601,362.40
Total Investments and Advances1,557.901,232.701,409.001,830.501,656.301,976.70
Intangible Assets114.60114.10115.50116.50116.70111.50
Deferred Tax Assets270.20311.60335.40446.80354.90456.20
Other Assets169.30147.90141.60143.10173.60174.30
Total Assets7,034.107,220.106,714.207,969.107,351.107,908.00
Short Term Debt Incl. Current Port. of LT Debt0.000.000.000.000.000.00
Accounts Payable520.20497.80498.30488.00468.00432.00
Other Current Liabilities104.10110.00100.8072.6078.3095.10
Total Current Liabilities624.30607.80599.10560.60546.30527.10
Long Term Debt0.000.000.000.000.000.00
Provision for Risks Charges0.000.000.0061.300.0028.80
Deferred Tax Liabilities---89.10--
Other Liabilities133.80212.00214.00161.90214.60178.50
Total Liabilities758.10819.80813.10872.90760.90734.40
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity6,276.006,400.305,901.107,096.206,590.207,173.60
Total Shareholders Equity6,276.006,400.305,901.107,096.206,590.207,173.60
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity6,276.006,400.305,901.107,096.206,590.207,173.60
Total Liabilities & Stockholders Equity7,034.107,220.106,714.207,969.107,351.107,908.00
Book Value Per Share148.08149.97139.98162.60153.61158.65
Tangible Book Value Per Share145.38147.30137.24159.93150.89156.19
Full-Time Employees---1,400--
Price to Book Ratio3.973.873.653.172.641.90
Return on Assets17.1117.3317.8117.3317.5716.98
Return on Equity19.1319.3220.2619.7120.0419.30
Return on Invested Capital4.125.204.665.135.144.31
Quick Ratio4.295.414.506.286.076.94
Current Ratio4.615.734.796.606.407.26

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income258.60333.00274.90364.30338.70309.50
Depreciation26.4024.2022.6022.8021.9021.10
Other Funds (Non Cash)10.7051.40127.505.4039.0064.10
Funds from Operations344.20434.30450.90490.20399.60394.70
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-37.70-124.1012.40-144.00162.50-203.00
Cash from Operating Activities306.50310.20463.30346.20562.10191.70
Capital Expenditures-180.70-108.00-100.80-172.90-216.00-62.20
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-345.80196.20850.20-59.80362.60-237.10
Purchase of Investments-558.90-69.10-726.70-545.30-415.90-1,806.90
Sale Or Maturity of Investments213.10265.301,576.90485.50778.501,569.80
Other Uses-3.50-0.70-5.705.10-5.70-0.60
Other Sources19.400.000.000.000.000.00
Cash from Investing Activities-510.6087.50743.70-227.60140.90-299.90
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-407.60126.30-1,426.1099.00-955.5018.10
Repurchase of Common Pref Stock-500.000.00-1,500.000.00-1,000.000.00
Sale of Common Pref Stock92.40126.3073.9099.0044.5018.10
Proceedsfrom Stock Options0.000.000.009.200.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.00-211.50
Change in Long Term Debt0.000.000.000.000.00-211.50
Issuance of Long Term Debt0.000.000.000.000.00188.50
Reduction of Long Term Debt0.000.000.000.000.00-400.00
Net Financing Active Other Cash Flow-2.60-0.50-58.30-0.60-0.50-5.20
Other Financing Activities Uses-2.60-0.50-58.30-0.60-0.50-5.20
Cash from Financing Activities-410.20125.80-1,484.4098.40-956.00-198.60
Net Change in Cash-614.30523.50-277.40217.00-253.00-306.80
Free Cash Flow125.80202.20362.50173.30351.60129.50
Price to Free Cash Flow28.4222.7827.5222.1517.6712.99

Revenue breakdown

Adcirca2024: 23.80M 2025: 30.00M
Nebulized Tyvaso2024: 586.80M 2025: 585.70M
Orenitram2024: 434.30M 2025: 496.90M
Product and Service, Other2024: 22.10M 2025: 24.00M
Remodulin2024: 538.10M 2025: 526.80M
Tyvaso DPI2024: 1.03B 2025: 1.29B
Unituxin2024: 238.70M 2025: 226.80M
Non-US2024: 137.70M 2025: 145.70M
United States2024: 2.74B 2025: 3.04B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.46%1.8M41.2M714.59K
2026-10-155.93%2.5M41.5M692.32K
2026-09-308.68%3.6M41.5M596.10K
2026-09-156.76%2.8M41.5M545.54K
2026-08-314.97%2.1M41.5M500.73K
2026-08-145.10%2.1M41.5M508.24K
2026-07-315.61%2.3M41.4M488.27K
2026-07-155.10%2.1M41.0M481.68K
2026-06-305.17%2.1M41.0M526.38K
2026-06-155.01%2.1M41.0M511.97K
2026-05-295.34%2.2M41.0M553.77K
2026-05-155.62%2.3M41.0M549.05K
2026-04-305.98%2.4M41.0M524.05K
2026-04-156.39%2.7M42.3M515.63K
2026-03-316.70%2.8M42.3M486.55K
2026-03-136.72%2.8M42.3M446.64K
2026-02-274.09%1.7M42.3M393.55K
2026-02-134.43%1.8M41.6M395.93K
2026-01-304.16%1.7M41.5M425.92K
2026-01-154.30%1.8M41.5M481.29K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call290304312.82742.9443.000.000.988-0.3910.029
call300294.2302.32642.7463.000.000.988-0.3900.030
call310284.2291.42542.4991.000.000.987-0.3890.031
call320274.2281.62442.4222.000.000.987-0.3870.032
call330264.2271.52342.3031.000.000.986-0.3860.033
call340254262.52242.3321.000.000.985-0.3850.035
call350244252.92522.2812.000.000.985-0.3830.036
call360234242.92082.1802.000.000.984-0.3810.038
call370224232.91982.0761.000.000.983-0.3790.039
call380214.12230.001.9900.000.000.982-0.3770.041
call390204.3211.20.001.6980.000.000.981-0.3750.043
call400194.1201.41441.6361.000.000.980-0.3730.044
call410184.4191.60.001.5730.000.000.979-0.3700.046
call420174.2183.10.001.6120.000.000.978-0.3680.049
call430164.2173.11721.5422.000.000.977-0.3650.051
call440154.2161.50.001.3170.000.000.976-0.3610.054
call450144.3152.875.801.3521.000.000.974-0.3580.056
call460134.71411071.1142.000.000.972-0.3540.059
call470124.91310.001.0390.000.000.970-0.3500.063
call480114.8121.11150.97411.000.000.968-0.3450.066
call490104.4113.391.001.0561.000.000.966-0.3400.071
call50094.90101.850.970.8802010.000.963-0.3350.075
call51084.9091.9092.850.8111010.000.960-0.3290.081
call52075.0081.4060.000.7052510.000.956-0.3210.087
call53065.1071.2029.300.6201020.000.951-0.3130.095
call54055.2061.4054.460.55913.001.000.944-0.3070.105
call55045.6051.8048.100.5061080.000.888-0.5110.177
call56036.5042.2050.030.4484430.000.831-0.6630.235
call57027.6033.9020.000.43112.000.000.794-0.6420.266
call58020.1025.3024.890.38167.000.000.719-0.7030.315
call59015.1018.2011.000.36656.002.000.613-0.7520.357
call60010.5011.9011.400.33983.0015.000.492-0.7440.372
call6106.107.5012.150.3304230.000.379-0.7470.355
call6203.204.303.400.3202,0792.000.270-0.6300.309
call6300.752.602.300.3223160.000.199-0.5520.261
call6400.651.500.980.3322811.000.124-0.3970.192
call6500.057.204.110.39635.000.000.096-0.3670.159
call6600.004.900.450.4692,0270.000.078-0.3570.136
call6700.004.903.700.51813.000.000.072-0.3700.128
call6800.051.050.550.4974601.000.055-0.2930.104
call6900.006.800.550.54410.001.000.049-0.2910.094
call7000.006.805.000.58712.000.000.046-0.2980.090
call7100.006.800.000.6380.000.000.041-0.2920.082
call7200.006.8021.000.6734.000.000.041-0.3100.082
call7400.006.8016.800.7513.000.000.037-0.3200.076
call7600.006.805.000.8252.000.000.034-0.3290.071
call7800.006.805.000.8950.000.000.032-0.3370.067
call7900.006.800.000.9290.000.000.031-0.3410.065
call8000.006.800.000.9630.000.000.030-0.3450.064
call8100.006.806.000.9961.000.000.029-0.3480.062
call8200.006.803.601.0292.000.000.029-0.3520.061
call8300.006.803.301.0603.000.000.028-0.3550.060
call8400.006.802.901.0914.000.000.027-0.3580.059
call8500.006.802.651.1224.000.000.027-0.3610.057
call8600.006.802.401.1524.000.000.026-0.3640.056
call8700.006.802.201.1832.000.000.025-0.3670.055
call8800.006.803.901.2113.000.000.025-0.3690.054
call8900.006.803.401.2394.000.000.024-0.3720.054
call9000.006.803.401.2685.000.000.024-0.3740.053
put2900.006.800.852.0493.000.00-0.008-0.2310.020
put3000.006.800.901.9613.000.00-0.008-0.2290.021
put3100.006.800.951.8752.000.00-0.009-0.2280.022
put3200.006.801.001.7934.000.00-0.009-0.2270.023
put3300.006.800.851.7120.000.00-0.009-0.2250.024
put3400.006.802.851.6341.000.00-0.010-0.2240.024
put3500.006.801.901.5583.000.00-0.010-0.2220.025
put3600.004.903.001.5817.000.00-0.016-0.3230.037
put3700.004.902.801.5048.000.00-0.017-0.3200.038
put3800.004.902.601.4296.000.00-0.017-0.3170.040
put3900.004.902.341.3566.000.00-0.018-0.3140.042
put4000.004.902.601.28562.000.00-0.019-0.3100.044
put4100.004.900.021.2157.000.00-0.020-0.3070.046
put4200.004.900.601.14719.000.00-0.021-0.3030.048
put4300.054.900.671.08010.000.00-0.023-0.2990.050
put4400.004.900.351.28311.000.00-0.068-0.8200.126
put4500.004.900.351.20558.000.00-0.072-0.8040.132
put4600.004.900.651.1275.000.00-0.076-0.7880.138
put4700.001.600.590.8091151.00-0.024-0.2350.052
put4800.104.900.700.74819.000.00-0.025-0.2310.055
put4900.004.900.950.90047.000.00-0.093-0.7300.160
put5000.004.901.250.6712940.00-0.046-0.3330.091
put5100.004.902.200.5392780.00-0.028-0.1780.059
put5200.000.951.300.5442960.00-0.044-0.2640.087
put5300.001.102.600.4815420.00-0.047-0.2450.092
put5400.300.950.950.4226191.00-0.056-0.2470.105
put5500.502.301.740.4531351.00-0.112-0.4500.178
put5600.104.904.800.4661530.00-0.169-0.6000.235
put5702.304.103.700.38418.005.00-0.206-0.5800.266
put5803.906.1010.000.36826.000.00-0.285-0.6480.317
put5908.208.908.700.34630.004.00-0.387-0.6860.357
put60011.3013.6013.500.34270.003.00-0.508-0.6770.372
put61016.9021.8027.700.4132.000.00-0.620-0.6820.355
put62023.6029.0096.200.4410.000.00-0.724-0.5760.312
put63031.7037.7070.100.4651.000.00-0.811-0.4520.252
put64041.0046.700.000.5030.000.00-0.878-0.3180.189
put65049.3056.301160.5551.000.00-0.902-0.2970.162
put66057.6066.0075.700.6050.000.00-0.918-0.2830.142
put67070.1075.701050.6511.000.00-0.925-0.2960.133
put68080.0085.701150.7370.000.00-0.945-0.2180.104
put69089.8095.70105.40.7930.000.00-0.949-0.2250.098
put70099.90105.71350.8480.000.00-0.952-0.2310.093
put710107.4116.20.000.8930.000.00-0.955-0.2370.089
put720117.4126.2138.70.9430.000.00-0.957-0.2420.085
put740137.4146.3149.31.0500.000.00-0.961-0.2510.079
put760157.4166.2178.81.1340.000.00-0.964-0.2590.074
put780177.4186.2225.11.2220.000.00-0.966-0.2660.070
put790187.4196.2204.11.2650.000.00-0.967-0.2690.068
put800197.4206.30.001.3170.000.00-0.968-0.2710.066
put810207.4216.20.001.3480.000.00-0.969-0.2740.065
put820217.4226.22551.3880.000.00-0.970-0.2770.063
put830227.4236.30.001.4380.000.00-0.971-0.2790.062
put840237.4246.20.001.4670.000.00-0.972-0.2810.061
put850247.4256.20.001.5050.000.00-0.972-0.2830.060
put860257.4266.20.001.5420.000.00-0.973-0.2850.058
put870267.4276.2299.51.5790.000.00-0.973-0.2870.057
put880277.4286.20.001.6150.000.00-0.974-0.2890.056
put890287.4296.30.001.6620.000.00-0.974-0.2900.056
put900297.4306.30.001.6740.000.00-0.975-0.2920.055

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-104Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-094Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-064Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-05144Filing for proposed sale of securities under Rule 144.SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-05SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-04SEC
2026-11-044Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-04SCHEDULE 13G/ASEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-034Statement of changes in beneficial ownership of securities2026-11-02SEC
2026-11-02144Filing for proposed sale of securities under Rule 144.SEC
2026-11-024Statement of changes in beneficial ownership of securities2026-10-30SEC
2026-10-304Statement of changes in beneficial ownership of securities2026-10-29SEC
2026-10-294Statement of changes in beneficial ownership of securities2026-10-28SEC
2026-10-284Statement of changes in beneficial ownership of securities2026-10-27SEC
2026-10-274Statement of changes in beneficial ownership of securities2026-10-26SEC
2026-10-264Statement of changes in beneficial ownership of securities2026-10-23SEC
2026-10-234Statement of changes in beneficial ownership of securities2026-10-22SEC
2026-10-224Statement of changes in beneficial ownership of securities2026-10-21SEC
2026-10-228-KCurrent report2026-10-21SEC
2026-10-214Statement of changes in beneficial ownership of securities2026-10-20SEC
2026-10-204Statement of changes in beneficial ownership of securities2026-10-19SEC
2026-10-194Statement of changes in beneficial ownership of securities2026-10-16SEC
2026-10-164Statement of changes in beneficial ownership of securities2026-10-15SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110039.09M11
2026-1000126.36M24
2026-0900107.04M25
2026-0800111.87M23
2026-0700116.08M25
2026-0600155.46M30
2026-0500163.14M31
2026-0400177.46M35
2026-0300141.12M38
2026-020047.54M10
2026-010051.81M12
2025-1200120.89M31
2025-1100126.19M29

Institutional holders

Manager% owned
BlackRock, Inc.12.47%
Avoro Capital Advisors LLC6.54%
VANGUARD PORTFOLIO MANAGEMENT LLC4.52%
VANGUARD CAPITAL MANAGEMENT LLC4.52%
STATE STREET CORP4.47%
RENAISSANCE TECHNOLOGIES LLC4.03%
WELLINGTON MANAGEMENT GROUP LLP3.25%
Amundi2.31%
GEODE CAPITAL MANAGEMENT, LLC2.27%
Jupiter Topco LLC1.96%

Funds

Fund% owned
iShares Core S&P Mid-Cap ETF3.42%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.18%
VANGUARD SMALL-CAP INDEX FUND2.29%
VANGUARD HEALTH CARE FUND1.69%
VANGUARD EXTENDED MARKET INDEX FUND1.15%
State Street SPDR S&P MidCap 400SM ETF Trust0.77%
VANGUARD SMALL-CAP VALUE INDEX FUND0.73%
iShares Biotechnology ETF0.69%
VANGUARD SMALL-CAP GROWTH INDEX FUND0.66%
Invesco S&P MidCap Quality ETF0.63%

OakChart. UTHR. Cached 15 minutes.